ClinConnect ClinConnect Logo
Search / Trial NCT03771508

Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)

Launched by MEDTRONIC - MITG · Dec 7, 2018

Trial Information

Current as of May 30, 2025

Active, not recruiting

Keywords

ClinConnect Summary

The SODA clinical trial is designed to gather information and videos from a special device called the PillCam SB3, which helps doctors see inside the small intestine. This trial is focused on various conditions affecting the small intestine, including diseases, cancer, and bleeding. It is a simple observational study, meaning participants will be involved in a standard procedure where the PillCam is used, and their videos and data will be collected for future research.

Anyone who has an SB3 procedure as part of their regular medical care can join this trial, as long as they understand what the study is about and agree to participate. There are no specific exclusions, so many people may be eligible. Participants can expect their PillCam videos and reports to be recorded and stored, helping researchers learn more about small intestine health. This study is currently recruiting participants of all ages and genders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All SB3 cases collected during standard of care procedures.
  • The subject received an explanation and understands the nature of the study and provided oral consenting
  • Exclusion Criteria:
  • None

About Medtronic Mitg

Medtronic - Minimally Invasive Therapies Group (MITG) is a leading global sponsor focused on advancing minimally invasive surgical techniques and technologies to improve patient outcomes and optimize healthcare delivery. Committed to innovation and excellence, MITG develops a range of products and solutions that enhance surgical precision and efficiency, catering to a diverse array of medical conditions. Through rigorous clinical trials and research initiatives, Medtronic MITG aims to drive evidence-based practices in healthcare, ensuring that patients benefit from the latest advancements in minimally invasive procedures.

Locations

Providence, Rhode Island, United States

Kansas City, Kansas, United States

Philadelphia, Pennsylvania, United States

Birmingham, Alabama, United States

Kansas City, Missouri, United States

Columbus, Ohio, United States

Worcester, Massachusetts, United States

Cleveland, Ohio, United States

Columbia, Maryland, United States

Hamden, Connecticut, United States

Toledo, Ohio, United States

Chesterfield, Missouri, United States

Oklahoma City, Oklahoma, United States

Jacksonville, Florida, United States

Miami, Florida, United States

Atlanta, Georgia, United States

Morristown, New Jersey, United States

Brooklyn, New York, United States

Lake Success, New York, United States

New York, New York, United States

Chevy Chase, Maryland, United States

Escondido, California, United States

Farmington Hills, Michigan, United States

Albany, New York, United States

Summerville, South Carolina, United States

Austin, Texas, United States

Exton, Pennsylvania, United States

Valencia, California, United States

Pikesville, Maryland, United States

Miami, Florida, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials